Status:
RECRUITING
The Effect of Survival, Response and Microbiota Change in Different Therapy Under Probiotic Supplement
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Probiotics
Cancer, Therapy-Related
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Probiotics are a group of viable microorganisms including bacteria and yeasts that if consumed in sufficient amounts, may afford health benefits to the host. The major advantage of probiotic administr...
Detailed Description
Probiotics are a group of viable microorganisms including bacteria and yeasts that if consumed in sufficient amounts, may afford health benefits to the host. The major advantage of probiotic administr...
Eligibility Criteria
Inclusion
- age≧20
- participants with cancer therapy and agree to sign informed consent
- Cancer confirmed by clinical or pathological diagnosis
Exclusion
- age\<20
- Pregnant or breastfeeding women
Key Trial Info
Start Date :
March 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 8 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06998823
Start Date
March 20 2024
End Date
November 8 2026
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New Taipei City TuCheng Hospital
New Taipei City, Taiwan